Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of <i>Mycobacterium tuberculosis</i>
Due to the concerning rise in the number of multiple- and prolonged-drug-resistant (MDR and XDR) <i>Mycobacterium tuberculosis</i> (Mtb) strains, unprecedented demand has been created to design and develop novel therapeutic drugs with higher efficacy and safety. In this study, with a foc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/10/1356 |